Literature DB >> 7602713

The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression.

J R Hoch1, V K Stark, W D Turnipseed.   

Abstract

PURPOSE: Intimal hyperplasia is a common cause of obstructive stenosis after arterial reconstructive procedures. It has been postulated that growth factors elaborated by vascular wall cells regulate fibroproliferative changes that can cause graft failure. This study characterizes transforming growth factor beta-1 (TGF-beta 1) and platelet-derived growth factor-A chain (PDGF-A) mRNA transcript profiles and their temporal relationship to the development of intimal hyperplasia in vein grafts.
METHODS: Epigastric vein-to-common femoral artery interposition grafts were performed in male Lewis rats (350 to 450 gm) with standard microsurgical techniques. Grafts were harvested at 1 and 4 hours, 1 and 4 days, and 1 and 2 weeks (n = 5/time). Graft RNA was extracted, reverse-transcribed, and amplified by polymerase chain reaction with sense/antisense primers for TGF-beta 1 and PDGF-A (30 cycles). Polymerase chain reaction fragments were confirmed by Southern hybridization.
RESULTS: Variable induction of TFG-beta 1 gene transcription was evident in vein grafts at 1 and 4 hours, with prominent mRNA expression from 1 day to 2 weeks. PDGF-A mRNA was detected in ungrafted control veins but was downregulated at 1 hour and absent at 4 hours after grafting. PDGF-A transcription was upregulated by 1 day, with prominent expression from 4 days to 1 week. Early loss of PDGF-A mRNA correlated with the early denudation of the endothelium, whereas upregulation by 4 days was preceded by TGF-beta 1 mRNA expression.
CONCLUSIONS: Upregulation of TGF-beta 1 and PDGF-A mRNA expression is detected in vein grafts before the development of a quantifiable neointima, which occurs by 2 weeks in our model. This suggests a role for these growth factors in the development of vein graft intimal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602713     DOI: 10.1016/s0741-5214(95)70088-9

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

1.  Inhibition of transforming growth factor-β restores endothelial thromboresistance in vein grafts.

Authors:  Navin K Kapur; Ce Bian; Edward Lin; Clayton B Deming; Jason L Sperry; Baranda S Hansen; Nikolaos Kakouros; Jeffrey J Rade
Journal:  J Vasc Surg       Date:  2011-07-31       Impact factor: 4.268

Review 2.  Gene therapy for vein grafts.

Authors:  M J Mann
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

3.  miR-16-5p Is a Novel Mediator of Venous Smooth Muscle Phenotypic Switching.

Authors:  Dengshen Zhang; Jun Shi; Guiyou Liang; Daxing Liu; Jian Zhang; Sisi Pan; Yuanfu Lu; Qin Wu; Changyang Gong; Yingqiang Guo
Journal:  J Cardiovasc Transl Res       Date:  2022-05-02       Impact factor: 4.132

4.  Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.

Authors:  Zhihua Jiang; Ming Tao; Kerri A Omalley; Danlu Wang; C Keith Ozaki; Scott A Berceli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

5.  TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.

Authors:  Brian C Cooley; Jose Nevado; Jason Mellad; Dan Yang; Cynthia St Hilaire; Alejandra Negro; Fang Fang; Guibin Chen; Hong San; Avram D Walts; Robin L Schwartzbeck; Brandi Taylor; Jan D Lanzer; Andrew Wragg; Abdalla Elagha; Leilani E Beltran; Colin Berry; Robert Feil; Renu Virmani; Elena Ladich; Jason C Kovacic; Manfred Boehm
Journal:  Sci Transl Med       Date:  2014-03-12       Impact factor: 17.956

6.  Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.

Authors:  Richard D Kenagy; Nozomi Fukai; Seung-Kee Min; Florencia Jalikis; Ted R Kohler; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

7.  Transforming growth factor-β in graft vessels: histology and immunohistochemistry.

Authors:  Shi-Min Yuan; Yan-Qing Wang; Yi Shen; Hua Jing
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Engineering an endothelialized vascular graft: a rational approach to study design in a non-human primate model.

Authors:  Deirdre E J Anderson; Jeremy J Glynn; Howard K Song; Monica T Hinds
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

Review 9.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

10.  Shear Stress Alterations Activate BMP4/pSMAD5 Signaling and Induce Endothelial Mesenchymal Transition in Varicose Veins.

Authors:  Karthika Chandran Latha; Ahalya Sreekumar; Vyshna Beena; Binil Raj S S; RaviKumar B Lakkappa; Ravi Kalyani; Radhakrishnan Nair; Saligrama Ramegowda Kalpana; Chandrasekharan C Kartha; Sumi Surendran
Journal:  Cells       Date:  2021-12-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.